Literature DB >> 14976240

E1A and E1B proteins inhibit inflammation induced by adenovirus.

Jerome Schaack1, Michael L Bennett, Jeff D Colbert, Andres Vazquez Torres, Gerald H Clayton, David Ornelles, John Moorhead.   

Abstract

Replication-defective human adenovirus (Ad) group C transducing vectors, most of which have the E1A, E1B, and E3 genes deleted, are highly inflammatory despite the fact that the parental viruses typically cause subclinical or mild infections. To investigate this paradox, the roles that the E1A, E1B, and E3 genes play in inflammation were tested by using replication-incompetent viruses carrying a deletion of the preterminal protein gene. The viruses were injected into BALB/c mouse ears, and edema was monitored as a sensitive surrogate marker of inflammation. A virus deleted for the E1A 289R (transcription activating) protein was noninflammatory, and inhibited edema induced by empty virus particles. The E1A 243R and E1B 55-kDa (p53 binding) proteins play the most important roles in inhibition of inflammation by the noninflammatory virus. The E1B 19-kDa antiapoptotic protein inhibited edema when both the E1A 243R and E1B 55-kDa proteins were expressed but strongly induced edema when only one was expressed. E3 proteins had their greatest effect on the inhibition of edema induced by the E1A 289R protein. The results support a model in which inflammation is countered through a mechanism that involves complex genetic interactions between Ad early region proteins and offer promise for the design and construction of noninflammatory Ad gene therapy vectors that are relatively easy to grow and purify.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14976240      PMCID: PMC365754          DOI: 10.1073/pnas.0303709101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  52 in total

1.  Adenovirus transduction of 3T3-L1 cells.

Authors:  D J Orlicky; J Schaack
Journal:  J Lipid Res       Date:  2001-03       Impact factor: 5.922

2.  Adenovirus-mediated expression of an olfactory cyclic nucleotide-gated channel regulates the endogenous Ca2+-inhibitable adenylyl cyclase in C6-2B glioma cells.

Authors:  K A Fagan; T C Rich; S Tolman; J Schaack; J W Karpen; D M Cooper
Journal:  J Biol Chem       Date:  1999-04-30       Impact factor: 5.157

3.  The release of inflammatory cytokines from human peripheral blood mononuclear cells in vitro following exposure to adenovirus variants and capsid.

Authors:  James N Higginbotham; Prem Seth; R Michael Blaese; W Jay Ramsey
Journal:  Hum Gene Ther       Date:  2002-01-01       Impact factor: 5.695

4.  Translational control is required for the unfolded protein response and in vivo glucose homeostasis.

Authors:  D Scheuner; B Song; E McEwen; C Liu; R Laybutt; P Gillespie; T Saunders; S Bonner-Weir; R J Kaufman
Journal:  Mol Cell       Date:  2001-06       Impact factor: 17.970

5.  Constitutive expression of the adenovirus E3-14.7K protein does not prolong adenovirus vector DNA persistence but protects mice against lipopolysaccharide-induced acute hepatitis.

Authors:  Murielle Gantzer; Estelle Spitz; Nathalie Accard; Ronald Rooke
Journal:  Hum Gene Ther       Date:  2002-05-20       Impact factor: 5.695

6.  Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons.

Authors:  N Morral; W O'Neal; K Rice; M Leland; J Kaplan; P A Piedra; H Zhou; R J Parks; R Velji; E Aguilar-Córdova; S Wadsworth; F L Graham; S Kochanek; K D Carey; A L Beaudet
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

7.  Promoter strength in adenovirus transducing vectors: down-regulation of the adenovirus E1A promoter in 293 cells facilitates vector construction.

Authors:  J Schaack; B Allen; D J Orlicky; M L Bennett; I H Maxwell; R L Smith
Journal:  Virology       Date:  2001-12-05       Impact factor: 3.616

8.  Inhibition of angiogenesis and induction of apoptosis are involved in E1A-mediated bystander effect and tumor suppression.

Authors:  R Shao; W Xia; M C Hung
Journal:  Cancer Res       Date:  2000-06-15       Impact factor: 12.701

9.  Inclusion of the E3 region in an adenoviral vector decreases inflammation and neointima formation after arterial gene transfer.

Authors:  S Wen; R M Driscoll; D B Schneider; D A Dichek
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-11       Impact factor: 8.311

10.  A replication-incompetent adenovirus vector with the preterminal protein gene deleted efficiently transduces mouse ears.

Authors:  J W Moorhead; G H Clayton; R L Smith; J Schaack
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

View more
  17 in total

Review 1.  Gene therapy: light is finally in the tunnel.

Authors:  Huibi Cao; Robert S Molday; Jim Hu
Journal:  Protein Cell       Date:  2012-01-10       Impact factor: 14.870

Review 2.  Intrinsic structural disorder in adenovirus E1A: a viral molecular hub linking multiple diverse processes.

Authors:  Peter Pelka; Jailal N G Ablack; Gregory J Fonseca; Ahmed F Yousef; Joe S Mymryk
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

3.  Replication of type 5 adenovirus promotes middle ear infection by Streptococcus pneumoniae in the chinchilla model of otitis media.

Authors:  Kyle A Murrah; Roberta L Turner; Bing Pang; Antonia C Perez; Jennifer L Reimche; Lauren B King; John Wren; Uma Gandhi; W Edward Swords; David A Ornelles
Journal:  Pathog Dis       Date:  2015-02-26       Impact factor: 3.166

4.  Strong foreign promoters contribute to innate inflammatory responses induced by adenovirus transducing vectors.

Authors:  Jerome Schaack; Michael L Bennett; Gary S Shapiro; James DeGregori; James L McManaman; John W Moorhead
Journal:  Virology       Date:  2011-01-20       Impact factor: 3.616

5.  Recombinant adenoviral vectors can induce expression of p73 via the E4-orf6/7 protein.

Authors:  Gary S Shapiro; Crystal Van Peursem; David A Ornelles; Jerome Schaack; James DeGregori
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

6.  A preliminary and comparative evaluation of a novel Ad5 [E1-, E2b-] recombinant-based vaccine used to induce cell mediated immune responses.

Authors:  Elizabeth S Gabitzsch; Younong Xu; Lois H Yoshida; Joseph Balint; Richard B Gayle; Andrea Amalfitano; Frank R Jones
Journal:  Immunol Lett       Date:  2008-12-13       Impact factor: 3.685

7.  Downregulation of varicella-zoster virus (VZV) immediate-early ORF62 transcription by VZV ORF63 correlates with virus replication in vitro and with latency.

Authors:  Susan E Hoover; Randall J Cohrs; Zoila G Rangel; Donald H Gilden; Peter Munson; Jeffrey I Cohen
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

8.  Adenovirus-mediated gene therapy enhances parainfluenza virus 3 infection in neonatal lambs.

Authors:  David K Meyerholz; Branka Grubor; Jack M Gallup; Howard D Lehmkuhl; Richard D Anderson; Tatjana Lazic; Mark R Ackermann
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

9.  Using viral vectors as gene transfer tools (Cell Biology and Toxicology Special Issue: ETCS-UK 1 day meeting on genetic manipulation of cells).

Authors:  Joanna L Howarth; Youn Bok Lee; James B Uney
Journal:  Cell Biol Toxicol       Date:  2009-10-15       Impact factor: 6.691

10.  The human adenovirus type 5 E1B 55 kDa protein obstructs inhibition of viral replication by type I interferon in normal human cells.

Authors:  Jasdave S Chahal; Ji Qi; S J Flint
Journal:  PLoS Pathog       Date:  2012-08-09       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.